Objectives: To compare the effects of free access to reduced fat products or their full fat equivalents on fat and energy intake, body weight, plasma lipids and fat-soluble antioxidants concentrations and haemostasis variables. Design: A multicentre open randomised controlled trial in which intervention and control groups were followed in parallel for six months. Volunteers had free access to 44 different foods either in reduced fat or full fat version, covering between 30 and 40% of energy intake. The remainder of energy intake was covered by foods bought in regular shops. Setting: Zeist, Wageningen and Maastricht, The Netherlands. Subjects: Two hundred and forty-one non-obese healthy volunteers who had no intention to lose weight. Main outcome measures: Food intake, body weight, plasma lipid, vitamin E, b-carotene, lycopene and ®brinogen concentrations, plasma factor VII clotting activity, and plasminogen-activator-inhibitor-I antigen level. Results: One hundred and three volunteers in the full fat group and 117 volunteers in the reduced fat group completed the study. Energy and fat intake from the free access products was lower in the reduced fat group, but no difference in energy and fat intake of other products occurred. Body weight, energy-, fat-and vitamin E intake and percentage of energy derived from fat decreased in the reduced fat group. No other statistical signi®cant intervention effects were observed. Blood lipid concentrations, factor VII activity and plasminogen-inhibitoractivator-1 level were reduced after consumption of reduced fat products. Conclusions: When subjects without intention to lose weight limit fat intake by switching from ad libitum consumption of full fat products to reduced fat products body weight gain is prevented, and fat and energy intake are reduced. Such a switch may have bene®cial effects on biochemical cardiovascular risk factors. We concluded that reduced fat products will help in a population strategy aimed at preventing overweight and obesity, they will also be effective in maintaining a lower body weight after slimming. Ad libitum consumption of reduced fat products will be ineffective for those individuals that want to reduce body weight because they are currently overweight or obese.
Introduction
During the last decade the prevalence of overweight and obesity has shown an alarming increase in Britain and the USA (Of®ce of Population Censuses and Surveys, 1984; White et al, 1993; Kuzcmarski et al, 1994) . Obesity and overweight are major sources of ill-health in af¯uent societies. Both conditions are associated with higher mortality from coronary heart disease and stroke. Also morbidity and mortality from gallbladder disease, diabetes, respiratory diseases and some cancers is increased (National Research Council, 1989) .
Obesity and overweight seem to be associated with a diet rich in fat and a sedentary lifestyle (Romieu et al, 1988; Klesges et al, 1992) . Fat-rich diets appear to permit passive overconsumption of energy due to their high energy density, and, possibly, relatively low satiating action (Cotton et al, 1994) . Lower rates of energy expenditure at work and at home, characteristic of the modern lifestyle, may also contribute toward an enhanced storage of dietary energy as body fat.
It is now recognized that it is very dif®cult to treat obesity and overweight with long term success (Council on Scienti®c Affairs, 1988) . Therefore mass prevention of unhealthy weight gain becomes very important. Health professionals have recommended for years a reduction in dietary fat intake. This advice has led to a growing public concern with the adverse effects on health of a high fat intake. The perceived health bene®ts of a lower fat intake has promoted a proliferation on the market of reduced fat products. It is assumed that consumption of such products will be bene®cial to the consumer. However, no data have been published of a randomized controlled trial in freeliving subjects of the effects of free access to such products for a prolonged period of time on food intake, body weight and biological variables. Strictly controlled laboratory studies using covert manipulations of the fat content of the diet have shown that fat and energy intake are reduced when the fat content of food is reduced (Lissner et al, 1987; Kendall et al, 1991) . The simple question whether a voluntary switch from commercially available full fat products to their reduced fat counterparts helps consumers in reducing energy and fat intake and body weight has not yet been answered for individuals outside a strictly controlled laboratory setting. We here report the results of an ef®cacy study of reduced fat products using a study set-up resembling the situation consumers face in real life. We investigated effects on food intake and body weight and on a number of biological variables, potentially, related to risk on cardiovascular disease. Our hypothesis was that free access to reduced fat products would cause a signi®cant decrease in energy and fat intake and body weight and would produce a more favourable blood lipid pro®le in comparison to free access to full fat products.
Subjects and methods

Subjects
This six month parallel comparison study was carried out simultaneously at three different research centres in Zeist, Wageningen and Maastricht in the Netherlands and coordinated by the Unilever Research Laboratorium in Vlaardingen, the Netherlands. Two hundred and forty-one nonobese volunteers were randomly assigned to a reduced fat products or a full fat products group. As the products were clearly labelled as such, volunteers were aware of their group assignment. It should be clear that we deliberately did not choose a blinded situation as we wanted to obtain results generalisable to the situation consumers face when they are offered reduced fat or full fat products in regular shops. Eligible subjects had stable weights, normal eating habits (no slimming or medically prescribed diet) and were healthy as assessed by a medical examination and routine clinical chemistry. Serum cholesterol levels at entry were below 8 mmolaL, age was between 19 and 55 y. Half of the volunteers were aged between 19 and 36 y and the other half were older. The body mass index for the younger groups was at entry between 20 and 28 and for the older group between 24 and 31 kg m
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. Exclusion criteria were intensive exercise (b 7 haw) and excessive alcohol consumption (b 21 alcoholic drinksaw for females; b 28 alcoholic drinksaw for males). Each research facility recruited about 80 eligible subjects by advertisement in regional newspapers. Volunteers were randomized over the full fat and reduced fat groups matched for mean age, body mass index, sex distribution, type of household and eating behaviour characteristics. All subjects gave their written informed consent for participation and the study protocol was approved by the Institutional Review Board of each centre.
Experimental procedures
At each research centre a small realistic supermarket provided full fat commercial products and their reduced fat alternatives. The available products, 44 for each treatment, ®tted in the normal diet of the volunteers and included items as frying fat, desserts, hard and cream cheeses, sausages, pate Âs, salads, dressings, deep frozen meals and pizzas, frozen ®sh ®ngers, cheese spreads, butter, margarines, frozen meat-based snacks, cookies and cakes. The full fat and reduced fat products were screened prior to the start of the study on sensory similarity, consumers' acceptance and nutrient composition. The products differed primarily in fat content (reduced fat products contained on average 52% less fat than the full fat products) and not in the other macronutrients. Forty-two products were commercially available products. Full fat and reduced fat cookies and cakes were prepared by the Unilever Research Laboratorium. The macronutrient content was derived from the manufacturer's information and the Dutch food composition table (Voorlichtingsbureau voor de Voeding, 1993) and checked by chemical analysis.
The volunteers visited the supermarket generally once a week. They were allowed to take as many products as they wished, and instructed not to share the products with their family or friends. The dieticians interviewed the volunteers after each visit to check compliance with the instructions. Products were free of charge, but volunteers had to make the effort to come shopping in the research centres. In addition to the products provided free of charge, volunteers bought other products, such as fruits, vegetables, snacks, drinks, meats, bread etc. in regular shops. Volunteers were free in their choice of these products. The experimental procedures have been described in detail previously (Hof van het et al, 1997). The study was designed to have a power of 90% to detect with a con®dence of 95%, assuming a drop-out rate of 20%, differences between both groups in energy intake, fat intake and fat energy percentage of 1.4 MJad (325 kcalad), 19 gad and 3.4%, respectively.
Measures
Total food intake was assessed just before the run-in period, and after 2± 4 w, three months and at the end of the actual study. At each point in time, food intake including the intake derived from the products provided by each centre, using household measures to estimate quantities, was recorded for three days (one day in the weekend). Macronutrient and vitamin E intake were calculated using the Dutch food composition table (Voorlichtingsbureau voor de Voeding, 1993) and data of the chemical analyses of the full fat and reduced fat products. Fasting venous blood samples were taken before, after two and four months and at the end of the study. At the same day of blood sampling, body weight was assessed with the subjects in underwear and after voiding. Serum total cholesterol, HDL-cholesterol, triacylglycerol levels were determined using commercial test kits. LDL-cholesterol level was calculated using the Friedewald formula (Friedewald et al, 1972) . For the Zeist cohort only, serum Lp(a) was assessed by a rate immunonephelometric assay. Haemostasis variables were also measured only for the Zeist cohort: ®brinogen was measured using a clotting rate method, factor VII clotting activity was measured with a chromogenic method (Chromogenix AB, Mo Èndal, Sweden) and plasminogen-activator-inhibitor-1 antigen was measured by ELISA (Coalize PAI-1aInnotest PAI-1, Chromogenix AB, Mo Èndal, Sweden). Also, only in the Zeist cohort plasma levels of vitamin E, beta-carotene and lycopene were determined by HPLC using UV detection. Body composition
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Statistical analysis
Intervention effects were evaluated for individuals who completed the whole trial using analysis of variance with sex and intervention as factors when assumptions of normality were met. To determine the intervention effect the changes between baseline values and values at each point in time during the trial were compared between both groups (reduced fat±full fat) for a statistically signi®cant (con®-dence of 95%) difference. There was great similarity in intervention effects throughout the trial, therefore most analyses are reported only for the changes between start and end (six months) of the study. Differences in dichotomized variables (education, restrained eating behaviour, type of household) at start between the full fat and reduced fat group were assessed by Fisher's exact test. Differences in blood lipids, body weight, and body fat content between initial low and high fat consumers were assessed by analysis of covariance, using sex, age and total energy intake as covariates. Intervention effects were also evaluated using initial body mass index or fat consumption as a covariate. SAS computer software was used for all statistical calculations (Statistical Analysis System Institute, 1987) . Table 1 shows characteristics of the volunteers at the start of the study. Twenty-one subjects, seventeen in the full fat and four in the reduced fat group, did for various reasons not complete the study. These subjects did not differ in entry characteristics from the volunteers who completed the study. As expected there were no signi®cant differences in entry characteristics between full fat and reduced fat groups at the start, neither for the male or female subgroup. We divided the total population at entry to the study in initial low (`35% energy from fat) or high ( !35%) fat consumers as we hypothesised that intervention effects might differ between these groups. We observed that energy intake adjusted for age and sex was lower in the initial low fat consumers (Table 2) . Body weight and body fat content were signi®cantly lower in the initial low fat consumers compared to the high fat consumers in contrast to plasma HDL-cholesterol level and the LDLaHDLcholesterol ratio.
Results
Volunteers
Energy, macronutrient and vitamin E intake Table 3 shows energy and vitamin E intake, the proportion of energy derived from the various macronutrients, alcohol and the various fatty acid classes in both groups before and at the end of the trial for the total group and for groups Table 2 Cross sectional analyses of differences in energy intake, body weight, body fat content, blood lipids levels in subjects with a high or low fat intake at entry to the study Effect of free access to reduced fat products JA Weststrate et al subdivided according to fat consumption at entry. There was a signi®cant intervention effect on energy, total fat, fatty acids and vitamin E intake. Energy, total fat, saturated fat, monounsaturated and polyunsaturated fatty acid intake increased signi®cantly in the full fat group compared to the reduced fat group. As a consequence there were signi®cant differences in the proportion of energy derived from total fat, the various fatty acid classes, carbohydrates and proteins between both groups. There were no differences between both sexes in these effects. The free access to reduced fat products induced a decrease in energy intake and in the percentage of energy from fat; this effect was most pronounced for those individuals that were classi®ed as high fat consumers at entry. None of the intervention effects was signi®cantly different between the initial low and high fat consumers. The experimental products provided on average 37% of energy intake in the full fat group and 30% in the reduced fat group. Mean fat and energy intake from free access products was 70 gad and 4.2 MJad in the full fat group and 37 gad and 3.1 MJad in the other group. Mean fat and energy intake from other foods was not different between both groups, 63 gad and 7.1 MJad. Table 4 shows absolute values and differences between both groups for body weight, blood lipids, ®brinogen and plasminogen-inhibitor-activator-1 antigen levels, factor VII clotting activity and plasma vitamin E, beta-carotene and lycopene levels. There was a signi®cant intervention effect on body weight at two and six months. Weight remained stable in the reduced fat group and it increased signi®cantly by about 1 kg in the full fat group. Average body weight changed gradually in the control group from 76.7 kg to 77.3, 77.5 and 77.8 kg at two, four and six months respectively. Mean body weight changed in the reduced fat group from 75.0 kg to 75.2, 75.2 and 75.4 kg at two, four and six months respectively. The difference between both groups in the change of fat mass (0.61 kg) was of borderline signi®cance (P 0.052). Sex, initial body mass index or fat consumption did not signi®cantly affect the weight changes.
Body weight, blood variables
In general, total cholesterol, LDL-cholesterol, HDLcholesterol and triacylglycerol levels were lower during the study in the reduced fat group compared to the full fat. The intervention effect was, however, not signi®cant. There was also no systematic intervention effect or sex by intervention interaction effect on the LDL to HDL ratio, serum Lp(a) and triglyceride levels, plasma levels of ®brinogen and plasminogen-inhibitor-activator-1 antigen, factor VII clotting activity and plasma vitamin E, beta-carotene and lycopene levels.
We observed that for a number of variables the intervention effect was not too different from the effect that would have been statistically signi®cant. Signi®cant intervention effects would have been obtained in the current study when blood lipid reductions had been 0.17 mmolaL (observed 0.16 mmolaL), 0.15 mmolaL (observed 0.10 mmolaL), 0.05 mmolaL (observed 0.03 mmolaL) and 0.14 mmolaL (observed 0.07 mmolaL) for serum total cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol concentrations, respectively. Also for factor VII activity and plasminogen-inhibitor-activator-1 antigen level the signi®cant effect was not too different from the observed effect, respectively 6.7% (observed 5%) and 18 ngamL (observed 10 ngamL). Effect of free access to reduced fat products JA Weststrate et al
Discussion
We here report data of a 6 months randomized trial in normal weight and moderately overweight adults of the ef®cacy of free access to reduced fat products to decrease energy and fat intake and to improve blood lipid pro®le. The study's most signi®cant results are that free access to reduced fat products versus their full fat equivalents prevents weight gain and reduces energy and fat intake and increases the percentage of energy derived from carbohydrates, especially for those individuals that have a high habitual fat consumption. The effects observed were relatively small. We observed that consumption of reduced fat products did lower, but not signi®cantly, blood levels of lipids, factor VII activity and plasminogen-inhibitor-activator-1 antigen level. Dietary guidelines in af¯uent countries universally emphasize a reduction in the intake of dietary fat, in particular of saturated fatty acids. In spite of these recommendations, average fat consumption in for example the USA and the UK, but also in Germany and the Netherlands is still exceeding what is recommended.
This study suggests that part of a population strategy to reduce the increasing prevalence of overweight and obesity involves a switch from the consumption of full fat products to their reduced fat alternatives. This is particularly true when the full fat products are rich in saturated or trans fatty acids. In addition, stimulating an increased energy use in daily life will also be important, perhaps even more important than limiting fat intake, in the prevention of weight gain as was recently suggested (Prentice & Jebb, 1995) .
In recent years reduced fat products have¯ooded the markets in Europe and Northern America. Laboratory investigations of the effect in humans of reducing the dietary fat content on spontaneous energy and fat intake have shown a decreased energy and fat intake (Lissner et al, 1987; Kendall et al, 1991) . Due to the strictly controlled nature of these studies, most of them have been limited to relatively small groups and have been of relatively short duration, in contrast to this study. Moreover most studies did not measure blood variables and used a covert manipulation of the fat content of the diet, a situation consumers do not readily encounter in practice as most reduced fat products are clearly labelled as such. Weight loss in subjects participating in 12 months ®eld trials of low-fat diets have produced a body weight lowering of between 1.5 and 2.5 kg, which is in good agreement with the ®ndings of this study (Sheppard et al, 1991; Lee-Han et al, 1988) . However, these trials are not comparable to our study as subjects were intensively counselled to reduce their fat intake. In our trial we obtained estimates of potential Effect of free access to reduced fat products JA Weststrate et al effects on body weight, food intake and a number of plasma parameters if individuals without the deliberate intention to lose weight would voluntarily decide to substitute a number of the full fat products they usually consume for reduced fat alternatives. The effects of the intervention in this study on weight gain were relatively small. A recent prospective study, however, showed that relatively small weight gains, namely between 5 and 11 kg over a period of 14 y (average less than 1 kg per year) were associated with a signi®cant increased risk for coronary heart disease in women aged 18 y and older (Willet et al, 1995) . Whether the small weight gain prevented in this study can be translated to a larger weight gain of for example 5 ±10 kg in a longer period of 5 ±10 y remains to be investigated.
Apart from the effects on food intake we assessed effects on blood lipids and fat-soluble antioxidant levels and haemostasis variables. It has been estimated that iso-energetic exchange of saturated dietary fat for carbohydrates would reduce total cholesterol, LDL-cholesterol and HDLcholesterol levels (Mensink & Katan, 1992) . Therefore, one of the adverse effects of introducing reduced fat products in the diet at the expense of full fat products might be a reduction in HDL-cholesterol levels. We observed a lowering of both LDL-and HDL-cholesterol concentrations in subjects consuming reduced fat products. The LDL to HDL-cholesterol ratio, an important predictor of coronary heart disease (Stampfer et al, 1991) , was not adversely affected by the treatment. A cross-sectional analysis of the total study population prior to the start of the study revealed an inverse association between HDL-cholesterol levels and the percentage of energy from fat, indicating that in af¯uent societies in a free living situation a lower fat intake might not necessarily be associated with reduced HDL-cholesterol levels, possibly due to a lower body weight. Indeed we found that body weight, adjusted for sex, age and energy intake was about 2.4 kg lower at entry to the study in subjects with a lower dietary fat intake, con®rming data by Romieu et al (Romieu et al, 1988) .
Levels of Lp(a), which has been proposed to be an independent risk factor for coronary heart disease (Schaefer et al, 1994) , were not adversely in¯uenced by the reduction in dietary fat intake. Increased ®brinogen, plasminogeninhibitor-activator-1 antigen levels and factor VII clotting activity may increase the risk of coronary heart disease (Kannel et al, 1987; Broadhurst et al, 1990; Hamsten et al, 1987) . Markmann et al (1993) , observed that prolonged consumption of a low fat high ®bre diet reduced these variables. We also observed lower factor VII activity and plasminogen-inhibitor-activator-1 antigen antigen levels in subjects consuming reduced fat products.
The signi®cant decrease in vitamin E intake in the reduced fat group was striking. The most important sources of vitamin E in the Dutch diet are vegetable oils, dressings and soft margarines (Kistemaker & van den Berg, 1993) . A reduction in the fat content of those products generally causes a reduction in the dietary vitamin E intake, which poses the question of forti®cation of such products with vitamin E. Adequate intake of vitamin E might be important in lowering the risk of coronary heart disease (Stampfer et al, 1993) .
Conclusions
This study suggests that a switch from full fat products to reduced fat alternatives will help prevent body weight gain in individuals who do not have the intention to change their body weight and will help to prevent overconsumption of dietary fat and energy. Such a switch may also have a small bene®cial effect on cardiovascular risk factors. Our data suggest that a substitution of reduced fat products for full fat products will be helpful in a population strategy for the prevention of obesity. A voluntary switch to these products without severely reducing energy intake as well will not be effective in reducing body weight in those individuals already overweight or obese. Reduced fat products can provide a nutritionally advantageous alternative for full fat products, in particular when these full fat products are rich in saturated or trans fatty acids. Supplementation with vitamin E of reduced fat products to the level occurring in the full fat equivalents may further increase the nutritional bene®ts of such products.
